Rapid detection of the prothrombin C20209T transition by light cycler analysis

• References

• 1 Poort S, Rosendaal FR, Reitsma PH. et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and a increase in venous thrombosis. Blood 1996; 88: 3698-703.
• 2 Danckwardt S, Gehring NH, Neu-Yilik G. et al. The prothrombin 3’end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-offunction mutations. Blood 2004; 104: 428-35.
• 3 Warshawsky I, Hren C, Sercia L. et al. Detection of a novel point mutation of the prothrombin gene at position 20209. Diagn Mol Pathol 2002; 11: 152-6.
• 4 Soo PY, Patel RK, Best S. et al. Detection of prothrombin gene polymorphism at position 20209 (PT20209C/T): Pilot study in a black population in the United Kingdom. Thromb Haemost 2005; 93: 179-80.
• 5 Ozelo MC, Annichino-Bizzacchie JM, Pollak ES. et al. Rapid detection of the prothrombin C20209T variant by differential sensitivity to restriction endonuclease digestion. J Thromb Haemost 2003; 1: 2683-5.
• 6 von Ahsen N, Schutz E, Armstrong VW. et al. Rapid detection of prothrombotic mutations prothrombin (G20210A), factor V (G1691A) and methylenetetrahydofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. Clin Chem 1999; 45: 694-6.
• 7 Nauk M, Marz W, Wieland H. Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden mutation detection kit and the LightCycler-Prothrombin mutation detection kit. Clin Biochem 2000; 33: 213-6.
• 8 Wittwer CT, Ririe KM, Anfew RV. et al. The Light- Cycler™: a microvolume multivolume fluorimeter with rapid temperature control. Biotechniques 1997; 22: 176-81.
• 9 Wylenzek M, Geisen C, Stapenhorst L, Wielckens K, Klinger KR. A novel point mutation in the 3’ region of the prothrombin gebne at position 20221 in a Lebanese/ Syrian family. Thromb Haemost 2001; 85: 943-4.